Literature DB >> 21895773

The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil.

Renato M Bakos1, Robert Besch, Gabriela G Zoratto, Janaína M Godinho, Nicolle G Mazzotti, Thomas Ruzicka, Lucio Bakos, Sidney E Santos, Patricia Ashton-Prolla, Carola Berking, Roberto Giugliani.   

Abstract

Several germline mutations and sequence variants in cancer predisposition genes have been described. Among these, the CDKN2A p.A148T variant appears to be frequent in patients with melanoma, at least in certain ethnic groups. In this case-control study, we evaluated 127 patients with cutaneous melanoma and 128 controls from Southern Brazil, the region with the highest melanoma incidence rates in the country. Using PCR-RFLP, we demonstrate that CDKN2A p.A148T variant was significantly more frequent in patients with melanoma than in controls (12.6% vs 3.9%; P=0.009). There was no association between presence of the polymorphism and tumor thickness, site of the primary tumor, melanoma subtype, age at diagnosis, quantitative and qualitative number of nevi. Patients with a positive family of history for other cancers were particularly prone to carry the CDKN2A p.A148T allele. All patients with p.A148T-positive melanoma reported European ancestry, especially German, and this was confirmed using a panel of ancestry-informative INDELs. Our data suggest that CDKN2A p.A148T is a melanoma susceptibility allele in Southern Brazil and is particularly common in patients with melanoma of predominantly European ancestry.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895773     DOI: 10.1111/j.1600-0625.2011.01332.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

1.  Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma.

Authors:  Alexandre Leon Ribeiro de Ávila; Ana Cristina Victorino Krepischi; Luciana Facure Moredo; Talita Ferreira Marques Aguiar; Felipe Carneiro da Silva; Bianca Costa Soares de Sá; Amanda França de Nóbrega; Maria Isabel Waddington Achatz; João Pedreira Duprat; Gilles Landman; Dirce Maria Carraro
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  Genetic Analysis of Brazilian Patients with Gallbladder Cancer.

Authors:  Cristina Sábato; Luciana Bastos-Rodrigues; Debora Chaves Moraes; Eitan Friedman; Luiz De Marco; Vivian Resende
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

3.  CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.

Authors:  Georgia Koulermou; Christos Shammas; Andreas Vassiliou; Tassos C Kyriakides; Constantina Costi; Vassos Neocleous; Leonidas A Phylactou; Maria Pantelidou
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

4.  Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.

Authors:  Anne Guyot; Mathilde Duchesne; Sandrine Robert; Anne-Sophie Lia; Paco Derouault; Erwan Scaon; Leslie Lemnos; Henri Salle; Karine Durand; François Labrousse
Journal:  J Neurooncol       Date:  2019-11-15       Impact factor: 4.130

5.  Genetic counseling in melanoma.

Authors:  Celia Badenas; Paula Aguilera; Joan A Puig-Butillé; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Dermatol Ther       Date:  2012 Sep-Oct       Impact factor: 2.851

6.  Epidemiology of melanoma in the South of Brazil: study of a city in the Vale do Itajaí from 1999 to 2013.

Authors:  Adma Silva de Lima; Carlos Efrain Stein; Karla Patricia Casemiro; Rodrigo Kraft Rovere
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

7.  Skin pigmentation polymorphisms associated with increased risk of melanoma in a case-control sample from southern Brazil.

Authors:  Larissa B Reis; Renato M Bakos; Fernanda S L Vianna; Gabriel S Macedo; Vanessa C Jacovas; André M Ribeiro-Dos-Santos; Sidney Santos; Lúcio Bakos; Patricia Ashton-Prolla
Journal:  BMC Cancer       Date:  2020-11-09       Impact factor: 4.430

8.  Effect of tumor suppressor gene cyclin-dependent kinase inhibitor 2A wild-type and A148T mutant on the cell cycle of human ovarian cancer cells.

Authors:  Zehua Bian; Yang Yu; Terigele Yang; Chao Quan; Wenjing Sun; Songbin Fu
Journal:  Oncol Lett       Date:  2014-02-11       Impact factor: 2.967

9.  Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients.

Authors:  Anna Przybyła; Katarzyna Lamperska; Andrzej Mackiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2015-09-28

10.  CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.

Authors:  Fani Karagianni; Ching-Ni Njauw; Katerina P Kypreou; Aravela Stergiopoulou; Michaela Plaka; Dorothea Polydorou; Vasiliki Chasapi; Leontios Pappas; Ioannis A Stratigos; Gregory Champsas; Peter Panagiotou; Helen Gogas; Evangelos Evangelou; Hensin Tsao; Alexander J Stratigos; Irene Stefanaki
Journal:  Acta Derm Venereol       Date:  2018-10-10       Impact factor: 4.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.